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Abstract
Our objective was to obtain Equine Arteritis Virus M protein in prokaryotic system to test it as immunogen. LP02/C Equine Arteritis Virus cDNA was used as 
template to obtain and clone this protein. Equine Arteritis M protein was cloned in the expression vector pQE30 and the recombinant plasmid pQE30/M was 
transformed in Escherichia Coli M15 cells. The OD600 values of the IPTG-induced M15-pQE30/M culture showed an inhibition of the kinetics growth compared 
with the non-induced M15-pQE30/M and positive M15-pQE40/DHFR cultures. Several factors such as growth temperature, IPTG concentration and different 
inductors were analyzed but any of them showed an improvement in protein expression. Instead of E. coli M15strain, a new strain (E. coli BL21) was used and 
transformed with the pQE30/M. This resolved in part the growth inhibition observed in E. coli M15 cells, but no the recovery yield of the protein. So, as all gene 
products that affect cells kinetics growth are considered to be toxic, we argue that the lower yields in M protein recovery could be attributed to an associated toxicity 
of EAV-M protein from LP02/C strain in this expression system.
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Introduction
Equine Viral Arteritis is a respiratory and reproductive horse 
disease caused by Equine Arteritis Virus (EAV) and it was first isolated 
in Ohio, USA, in 1953 [1,2]. It has been classified as a member of the 
Arteriviridae family, Nidovirales order, and grouped together with lactate 
dehydrogenase-elevating virus, porcine reproductive and respiratory 
syndrome virus (PRRSV), and simian hemorrhagic fever virus [3].
EAV is a small enveloped virus with a positive sense and single-
stranded RNA genome of 12.7 kb which includes ten functional open 
reading frames (ORFs) [4]. ORFs 1a and 1b encode two replicase 
polyproteins [3] and the remaining eigth ORFs (2a, 2b, and 3 to 7) 
encode the structural proteins of EAV. The EAV structural proteins 
include five membrane glycoproteins (GP), GP2, GP3, GP4, GP5, and 
OF5a protein, encoded by ORFs 2b, 3, 4, 5 and 5a respectively; two 
unglycosylated membrane proteins, E and M, encoded by ORFs 2a and 
6; and the remaining ORF 7 encoded for phosphorylated nucleocapsid 
protein N [5-7].
The predicted ORF 6 product has a molecular weight of 
approximately 18 kDa. It lacks N-glycosylation sites, and it contains 
five methionines and one cysteine. The only cysteine present in the N 
terminal of the M protein, Cys 8, is linked with one of the cysteines 
present in the ectodomain of the membrane glycoprotein GP5 (Cys 34) 
and forms disulfide-linked heterodimers (M/GP5) [8]. 
The M protein is the most conserved structural protein in EAV 
and in PRRSV [9,10]. It has been reported the tendency of M protein 
to aggregate and form homodimers in EAV and in PRRSV, but this 
conformation of M protein was not incorporated in the mature virions. 
This tendency to aggregation was also found in Coronavirus family 
[9]. The structure, the membrane-associated function and the 
hidrofobicity profile of the M protein resemble all members of the 
Nidovirales order [11]. 
The M protein was the most consistently recognized EAV protein 
recognized by seroneutralization positive sera from naturally and 
experimentally infected horses [12-14]. The deletion of the N-terminal 
87 amino acids did not abolish the immune reactivity of the protein, 
demonstrating the antigenicity of the C-terminal region (amino acids 
88 to 162) [15].
In this work, we aimed to produce and recover EAV-M protein to 
test it as immunogen. Nevertheless, we provide a detailed analysis that the 
expression of EAV-M protein in the prokaryotic system E.coli M15 strain 
and pQE30 vector has an inherent toxicity and consequence produce a 
marked inhibition in cell growth that could not be reverted.
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Material and methods
Obtaining of ORF6 gene from LP02/C and clone into pQE30 
plasmid
Viral RNA from the Argentinean LP02/C EAV strain was extracted 
from infected rabbit kidney(RK13) cell cultures [16]. The EAV RNA was 
reversely transcribed and amplified using Moloney Murine Leukemia 
Virus Reverse Transcriptase (Promega, Madison, Wisconsin, USA) 
and Random Hexamers (New England Biolabs, Madison, Wisconsin, 
USA). The EAV ORF 6 encoding region was amplified using the cDNA 
obtained as a template. A pair of primers was designed including a 
recognition site sequence for BamHI and SacI restriction enzymes to 
allow the subsequent cloning into the pQE30 expression vector (Qiagen). 
The sense and antisense primers designed for pQE30 cloning were: 
pQEMBamHI 5’-GGGGATCCGGAGCCATAGATTCATTTTG-3’ 
(nucleotides 11903 to 11922) and pQEMSacI 
5’-TTGAGCTCCGCAGTAGGTCATTGTAGCTT-3’ (nucleotides 
12377 to 12398). The underlined nucleotides were the restriction 
enzyme sites added to the primers for the subsequent digestion. The 
EAV ORF 6 PCR product (511bp) was purified with the Wizard SV 
Gel and PCR Clean-Up System (Promega), digested with BamHI and 
SacI restriction enzymes and cloned into the pQE30 expression vector 
previously digested with the same restriction enzymes.
Transformation of pQE30/M in Escherichia coli M15 (pREP4)
Competent E. coli M15 (pREP4) were transformed with pQE30/M 
construction. Briefly, competent cell tube was incubated on ice for 30 
minutes. Then cells were incubated in a 42°C water bath for 60 seconds 
followed incubation on ice for 2 minutes. It was added 0, 9 ml of 
preheated SOC medium to the tube and incubated at 37°C for 1 hour 
with shaking at 250 rpm. Finally, 200 µl of the transformation mixture 
was seed in LB agar plates containing antibiotics (100 µl/ml ampicillin 
and 25 µl/ml kanamycin -pREP4 confer the kanamycin resistance). 
Colonies were analyzed by PCR with pQE Sequencing Primer Set from 
The QIAexpressionist (Qiagen) to detect the EAV ORF6. PCR from 
pQE30 backbone sized 335 bp. Finally, positives PCR clones (pQE30 
335bp + EAV ORF 6 511 bp) were recovered and purified by miniprep.
Induction of EAV-M protein in E. coli M15 (pREP4) and 
evaluated factors
Initially, for expression of EAV-M protein, E. coli M15 (pREP4) 
transformed with the recombinant plasmid pQE30/M (M15-
pQE30/M) were propagated in Luria Bertani (LB) medium with 100 
µg/ml ampicillin and 25 µg/ml kanamycin at 37°C with shaking. When 
M15-pQE30/M culture grew to logarithmic phase - optical density at 
600nm (OD600) of 0.6 -, 1mM of Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) was added to induce expression of the EAV-M protein. We have 
used pQE40-DHFR (Qiagen) expressing the Dihydrofolate Reductase 
(DHFR), a 26 kDa protein, as positive expression control. Cells were 
monitored spectrophotometrically both for induced and non-induced 
cultures.
We evaluated different factors that affect protein expression such as 
incubation temperatures (4°C, 30°C and 37°C), IPTG concentrations 
(1mM and 0.1mM), antibiotic concentration, lactose as inductor and 
other E. coli strain BL21(pREP4). 
Polyacrylamide gel and Western Blot analysis 
Samples from each culture conditions were analysed on sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and 
the gel stained with Coomassie brilliant blue R-250.
Western Blot we revealed using polyclonal EAV positive antibodies 
and monoclonal anti-histidine antibodies (GE Healthcare, Freiburg, 
Germany). As secondary antibodies, peroxidase-conjugated anti-horse 
and anti-mouse were used (Sigma Chemical, St. Louis, Missouri, USA).
Results and discussion
Minipreps of pQE30/M recombinant plasmid
Twelve positive clones grown in LB plates with antibiotics 
were picked and verified the presence of EAV ORF6 by PCR with 
pQE Sequencing Primer Set from The QIAexpressionist (Qiagen). 
Nine of the colonies analyzed evidence the presence of EAV ORF6 
(PCR product of 846 bp) (Figure 1). These positive clones carrying 
recombinant plasmids pQE30/M were recovered by miniprep and 
the DNA sequencing of five positive clones confirmed that the EAV 
ORF 6 sequence was in frame in the pQE30 expression vector (data 
not shown).
Evaluation of EAV-M protein expression in E. coli M15 
(pREP4) at 37°C induced with 1mM of IPTG
A culture of M15-pQE30/M was induced to express EAV-M 
protein using 1mM of IPTG and 37°C. The OD600 values of the induced 
culture showed an inhibition of the kinetics growth compared with the 
non-induced M15-pQE30/M and positive M15-pQE40/DHFR culture 
at all the time intervals monitored (Table 1 and Figure 2a).
Samples from each culture were analyzed on sodium dodecyl 
sulphate-polyacrilamide gel electrophoresis (SDS-PAGE) and the gel 
stained with Coomassie brilliant blue R-250 showed the expression of 
the control DHFR protein (26kDa), although it did not evidence any 
band at the molecular weight of the EAV-M protein (18 kDa) in the 
induced culture (data not shown). However, the presence of a band 
of the expected molecular size corresponding to EAV-M protein 
was revealed through Western Blot using polyclonal EAV positive 
antibodies and monoclonal anti-histidine antibodies (Figure 3a). The 
Figure 1. PCR using pQE sequencing primer set on transformed colonies of E. ColiM15. 
Line 1:100bp ladder. Lines 2, 3, 5, 6, 7, 9, 10, 12, 13: positive colonies carrying the insert 
of interest (M15-pQE30/M). Lines 4, 8, 11: negative colonies (M15-pQE30).





0 0.55 0.620 0.539 
1 0.745 0.612 0.685 
2 0.961 0.587 0.835 
3 0.589 (1/2) 0.510 0.521 (1/2) 
4 0.732 (1/2) 0.495 0.624 (1/2) 
5 0.798 (1/2) 0.498 0.687 (1/2) 
6 0.821 (1/2) 0.492 0.704 (1/2) 
Table 1. The OD600 values of the M15-pQE30/M induced and non-induced, and induced 
M15-pQE40/DHFR at all the intervals times monitored. Time 0 refers to the initiation of 
induction. The number in brackets indicate the dilution of the sample prior to measurement. 
Conditions of induction: 1mM IPTG, 100 µg/ml ampicillin and 25 µg/ml kanamycin, 37ºC.
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anti-histidine blotting showed two protein bands at approximately 18 
kDa and 35 kDa, indicating the formation of M/M dimmer. So, the 
identification of EAV-M protein only by Western Blot evidenced the 
higher sensitivity of this technique in the detection of lower protein 
concentrations [17].
Analysis of different factors that influence protein expression 
in E. coli
Several factors could influence protein expression in prokaryotic 
systems [18,19]. The reduction of culture growth temperature allows 
more time for protein folding by diminishing the growth kinetics of 
cultures and, consequently, proteins expression. As a first analysis, the 
culture growth temperature was reduced to 30ºC; prior to the IPTG 
induction, all cultures growth were slightly less than the growth at 
37ºC. After IPTG induction, the non-induced and positive cultures 
maintained these reduction in growing compared with cultures at 
37°C but their growth was not limited. However, induced M15-
pQE30/M culture showed the same growth inhibition as presented at 
37ºC. Chirnside, et al. [20], obtained improvements in EAV protein 
expression in prokaryotic systems when the temperature was reduced. 
Nevertheless, no improvements were obtained in this work.
IPTG is a sulfur toxic molecule at high concentration because it 
could not be metabolized by cells. IPTG concentration was decreased 
to 0.1 mM but M15-pQE30/M culture was still limited in their growth. 
By contrast, some authors reported the addition of 2mM of IPTG for 
the induction of expression of EAV-GP5 protein in M15-pQE9 without 
having any obstacle in the recovery of this protein [21]. When IPTG 
was replaced with lactose as inductor, M15-pQE30/M culture showed 
the same inhibition pattern indicating that the inhibition effect was not 
attributed to the addition of IPTG. 
Plasmids impose a metabolic stress on their hosts, giving an 
advantage in culture to plasmid-free cells. The inefficient selection 
pressure by antibiotics could be responsible for the loss of plasmid in 
successive bacteria replication [22]. The addition of twofold ampicillin 
concentration into the culture as positive selector did not improve the 
protein expression yield. 
E. coli BL21 strain harboring pREP/4 was the new strain selected for 
transformation with the construction previously obtained in order to 
analyze the inhibition conditions observed in E. coli M15 strain. After 
the transformation, BL21-pQE30/M obtained was propagated at the 
same initial conditionsas M15-pQE30/M cultures (1 mM IPTG, 100 
µg/ml ampicillin and 25 µg/ml kanamycin, 37ºC). The values of OD600 
of the induced BL21-pQE30/M culture showed a slight growth increase 
compared with the induced M15-pQE30/M culture (Table 2 and Figure 
2b). In this new system, the inhibition of bacteria growth was solved in 
part because the OD600 values rose 0.3 point after adding IPTG. As 
in M15/pREP4, the expression of EAV M protein in BL21/pREP4 was 
detected only in Western Blot (Figure 3b) but no in polyacrylamide 
gels. We observed only a band of 18 kDa and no dimer M/M protein 
was detected in E. coli BL21 as compared with E. coli M15.
In this work, several factors were analyzed in the EAV-M 
expression in E. coli M15 cells and none of them showed an 
improvement in protein expression. As all gene products that affect 
cells kinetics growth are considered as toxic, we argue that the lower 
yields in EAV-M recovery could be attributed to an associated toxicity 
of EAV-M protein expression in this system or also to instability of the 
construction, as other expression system of EAV-M protein did not 
evidence this growth inhibition [15,23,24].
By a simple set of experiments we provided evidence about the 
inhibition of growth rate in E. coli M15 carrying the recombinant 
plasmid pQE30/M and expressing EAV M protein. We evidenced a 
higher inhibition of growth in these cells rather than E. coli BL21. Also, 
our investigation revealed that Western Blot using EAV polyclonal 
Figure 2. a) Growth rate kinetics between M15-pQE30/M induced and non-induced and M15-pQE40/DHFR induced. b) Comparison of growth rate kinetics between BL21-pQE30/M 
induced and non-induced and BL21-pQE40/DHFR induced..
Figure 3.  A) Western Blot analysis of expression of EAV-M protein inE.ColiM15 strain. 
Line 1: non-induced M15-pQE30/M with polyclonal EAV positive serum. Line 2: induced 
M15-pQE30/M withpolyclonal EAV positive serum. Line 3: induced M15-pQE30/M with 
monoclonal anti-histidine. Line4: non-induced M15-pQE30/M with monoclonal anti-
histidine. Line 5: induced M15-pQE40/DHFRwith monoclonal anti-histidine. B) Line 6: 
BL21-pQE30/M induced with monoclonal anti-histidine. Allsamples were taken at t=6h of 
the experience and all were seed in non-reducing conditions.
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serum showed a band corresponding to dimer M/M protein in E. coli 
M15 (Figure 3a) that was not identified in E. coli BL21. Although more 
research is required for a definitive conclusion, the associated toxicity 
could be linked to the hydrophobic region of EAV-M protein, which 
prompts us to suggest that toxic effects are related to the general stress 
responses elicited against misfolding prone protein domains [25]. 
The previous evidence of M protein dimerization in M15 cells 
could be another causative explanation for this toxicity. Jeronimo 
and Archambault [15] have produced intact and truncated M fusion 
proteins in prokaryotic system using Bucyrus strain. The lower degree 
of protein expression for wild type M protein and the larger M protein 
fragment was believed to be related to the predicted low solubility 
index of the M-protein N terminus, as suggested by the predominant 
presence of three highly hydrophobic domains in this region of the 
protein.
The hydropathy profile of the ORF 6 protein from Equine 
Arteritis Virus is remarkably similar to that of the membrane protein 
of Coronavirus [9,26]. In this relation, the expression of the M 
protein from porcine epidemic diarrhoea virus, which belongs to the 
Nidovirales order and the Coronavirus family, was found to damage the 
cell wall, producing growth inhibition [15]. All previous report of M 
protein expression from EAV was done using Bucyrus strain or related 
strain, all belonging to the group of American strains. This is the first 
report of the use of EAV LP02/C Argentinean strain, grouped together 
with all Argentinean strains in European EAV cluster [16]. In spite 
of this cluster difference, the sequence of both EAV-M Bucyrus and 
LP02/C strains has high similarity values when both sequences were 
compared by Blast search, so this difference may not be in relation with 
the lower yield of culture growth.
Conclusion
E. coli is a host of choice for expression prokaryotic proteins and 
from diverse eukaryotes non-glycosylated proteins. Nevertheless, the 
expression of some of these proteins has shown an inhibitory effect 
on the E. coli growth. In such cases, the expression yields are severely 
diminished or sometimes abolished. The expression can fail because 
the putative protein generated may not be the same in conformation, 
folding and post traductional modification, compared with the viral 
protein. All the parameters must be studied and fixed in each particular 
expression system [18].
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